{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:49:23Z","timestamp":1768070963919,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inf Syst Front"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s10796-017-9764-0","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T08:15:50Z","timestamp":1496304950000},"page":"1233-1241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Revealing determinant factors for early breast cancer recurrence by decision tree"],"prefix":"10.1007","volume":"19","author":[{"given":"Jimin","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin C. M.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farkhund","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J. K.","family":"Kuppen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob A. E. M.","family":"Tollenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilma E.","family":"Mesker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"issue":"5","key":"9764_CR1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s13277-012-0411-6","volume":"33","author":"S Ahn","year":"2012","unstructured":"Ahn, S., Cho, J., Sung, J., Lee, J. E., Nam, S. J., Kim, K. M., & Cho, E. Y. (2012). The prognostic significance of tumor-associated stroma in invasive breast carcinoma. Tumour biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 33(5), 1573\u20131580.","journal-title":"Tumour biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"10","key":"9764_CR2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0344-0338(11)80596-0","volume":"191","author":"M Aubele","year":"1995","unstructured":"Aubele, M., Auer, G., Voss, A., Falkmer, U., Rutquist, L., & Hofler, H. (1995). Disease-free survival of node-positive breast-cancer patients - improved prognostication by cytometric parameters. Pathology, Research and Practice, 191(10), 982\u2013990.","journal-title":"Pathology, Research and Practice"},{"issue":"11","key":"9764_CR3","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/bjc.2012.166","volume":"106","author":"S Barton","year":"2012","unstructured":"Barton, S., Zabaglo, L., A'Hern, R., Turner, N., Ferguson, T., O'Neill, S., Hills, M., Smith, I., & Dowsett, M. (2012). Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer. British Journal of Cancer, 106(11), 1760\u20131765.","journal-title":"British Journal of Cancer"},{"issue":"16","key":"9764_CR4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/jnci\/djn233","volume":"100","author":"AM Brewster","year":"2008","unstructured":"Brewster, A. M., Hortobagyi, G. N., Broglio, K. R., Kau, S. W., Santa-Maria, C. A., Arun, B., Buzdar, A. U., Booser, D. J., Valero, V., Bondy, M., & Esteva, F. J. (2008). Residual risk of breast cancer recurrence 5 years after adjuvant therapy. Journal of the National Cancer Institute, 100(16), 1179\u20131183.","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"9764_CR5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.bjc.6605863","volume":"103","author":"HE Campbell","year":"2010","unstructured":"Campbell, H. E., Gray, A. M., Harris, A. L., Briggs, A. H., & Taylor, M. A. (2010). Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK. British Journal of Cancer, 103(6), 776\u2013786.","journal-title":"British Journal of Cancer"},{"key":"9764_CR6","unstructured":"Carlson, R. (2010). Surveillance of patients following primary therapy. In Diseases of the breast, 4 edn. Lippincott Williams and Wilkins."},{"issue":"3","key":"9764_CR7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10549-010-0855-6","volume":"125","author":"EM Kruijf de","year":"2011","unstructured":"de Kruijf, E. M., van Nes, J. G., van de Velde, C. J., Putter, H., Smit, V. T., Liefers, G. J., Kuppen, P. J., Tollenaar, R. A., & Mesker, W. E. (2011). Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Research and Treatment, 125(3), 687\u2013696.","journal-title":"Breast Cancer Research and Treatment"},{"issue":"2","key":"9764_CR8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/annonc\/mds333","volume":"24","author":"EM Kruijf de","year":"2013","unstructured":"de Kruijf, E. M., Dekker, T. J., Hawinkels, L. J., Putter, H., Smit, V. T., Kroep, J. R., Kuppen, P. J., van de Velde, C. J., ten Dijke, P., Tollenaar, R. A., & Mesker, W. E. (2013). The prognostic role of TGF-beta signaling pathway in breast cancer patients. Annals of Oncology : Official Journal of the European Society for Medical Oncology \/ ESMO, 24(2), 384\u2013390.","journal-title":"Annals of Oncology : Official Journal of the European Society for Medical Oncology \/ ESMO"},{"issue":"2","key":"9764_CR9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10549-013-2571-5","volume":"139","author":"TJ Dekker","year":"2013","unstructured":"Dekker, T. J., van de Velde, C. J., van Pelt, G. W., Kroep, J. R., Julien, J. P., Smit, V. T., Tollenaar, R. A., & Mesker, W. E. (2013). Prognostic significance of the tumor-stroma ratio: Validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Research and Treatment, 139(2), 371\u2013379.","journal-title":"Breast Cancer Research and Treatment"},{"issue":"7","key":"9764_CR10","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/bjc.2014.69","volume":"110","author":"CL Downey","year":"2014","unstructured":"Downey, C. L., Simpkins, S. A., White, J., Holliday, D. L., Jones, J. L., Jordan, L. B., Kulka, J., Pollock, S., Rajan, S. S., Thygesen, H. H., Hanby, A. M., & Speirs, V. (2014). The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer. British Journal of Cancer, 110(7), 1744\u20131747.","journal-title":"British Journal of Cancer"},{"issue":"2","key":"9764_CR11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1309\/AJCP8A2UVLCYGTPU","volume":"131","author":"NN Esposito","year":"2009","unstructured":"Esposito, N. N., Dabbs, D. J., & Bhargava, R. (2009). Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases. American Journal of Clinical Pathology, 131(2), 228\u2013242.","journal-title":"American Journal of Clinical Pathology"},{"issue":"3","key":"9764_CR12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01840834","volume":"22","author":"MH Galea","year":"1992","unstructured":"Galea, M. H., Blamey, R. W., Elston, C. E., & Ellis, I. O. (1992). The Nottingham prognostic index in primary breast cancer. Breast Cancer Research and Treatment, 22(3), 207\u2013219.","journal-title":"Breast Cancer Research and Treatment"},{"key":"9764_CR13","doi-asserted-by":"crossref","unstructured":"Gujam, F. J., Edwards, J., Mohammed, Z. M., Going, J. J., & McMillan, D. C. (2014). The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer. British Journal of Cancer, 111(1), 157\u2013165.","DOI":"10.1038\/bjc.2014.279"},{"issue":"1","key":"9764_CR14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/annonc\/mds246","volume":"24","author":"A Huijbers","year":"2013","unstructured":"Huijbers, A., Tollenaar, R. A., van Pelt, G. W., Zeestraten, E. C., Dutton, S., McConkey, C. C., Domingo, E., Smit, V. T., Midgley, R., Warren, B. F., Johnstone, E. C., Kerr, D. J., & Mesker, W. E. (2013). The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: Validation in the VICTOR trial. Annals of Oncology : Official Journal of the European Society for Medical Oncology \/ ESMO, 24(1), 179\u2013185.","journal-title":"Annals of Oncology : Official Journal of the European Society for Medical Oncology \/ ESMO"},{"issue":"11","key":"9764_CR15","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/bjc.2011.145","volume":"104","author":"PL Jerevall","year":"2011","unstructured":"Jerevall, P. L., Ma, X. J., Li, H., Salunga, R., Kesty, N. C., Erlander, M. G., Sgroi, D. C., Holmlund, B., Skoog, L., Fornander, T., Nordenskjold, B., & Stal, O. (2011). Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial. British Journal of Cancer, 104(11), 1762\u20131769.","journal-title":"British Journal of Cancer"},{"key":"9764_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/381428","volume":"2012","author":"JJ Lebrun","year":"2012","unstructured":"Lebrun, J. J. (2012). The dual role of TGF in human cancer: From tumor suppression to cancer metastasis. ISRN Molecular Biology, 2012, 1\u201328.","journal-title":"ISRN Molecular Biology"},{"key":"9764_CR17","unstructured":"Lee, H. M., & Hsu, C. C. (1990). A new model for concept classification based on linear threshold unit and decision tree. Proceedings of the International Joint Conference on Neural Networks (IJCNN-90-Wash D.C. IEEE\/INNS), Washington, D.C., USA, vol. 2, pp. 631\u2013634."},{"issue":"12","key":"9764_CR18","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.ejca.2005.03.032","volume":"41","author":"MS LM","year":"2005","unstructured":"LM, M. S., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., Clark, G. M., & Statistics Subcommittee of the NCIEWGoCD. (2005). REporting recommendations for tumour MARKer prognostic studies (REMARK). European Journal of Cancer, 41(12), 1690\u20131696.","journal-title":"European Journal of Cancer"},{"issue":"9","key":"9764_CR19","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1158\/1078-0432.CCR-07-5026","volume":"14","author":"XJ Ma","year":"2008","unstructured":"Ma, X. J., Salunga, R., Dahiya, S., Wang, W., Carney, E., Durbecq, V., Harris, A., Goss, P., Sotiriou, C., Erlander, M., & Sgroi, D. (2008). A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 14(9), 2601\u20132608.","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"2","key":"9764_CR20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massague","year":"2008","unstructured":"Massague, J. (2008). TGFbeta in cancer. Cell, 134(2), 215\u2013230.","journal-title":"Cell"},{"issue":"3","key":"9764_CR21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-5793(95)00247-7","volume":"362","author":"P Mazars","year":"1995","unstructured":"Mazars, P., Barboule, N., Baldin, V., Vidal, S., Ducommun, B., & Valette, A. (1995). Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells. FEBS Letters, 362(3), 295\u2013300.","journal-title":"FEBS Letters"},{"key":"9764_CR22","unstructured":"Mitchell, T. M. (1997). Machine learning. The McGraw-Hill Companies, Inc., New York."},{"issue":"4","key":"9764_CR23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejso.2012.01.002","volume":"38","author":"AM Moorman","year":"2012","unstructured":"Moorman, A. M., Vink, R., Heijmans, H. J., van der Palen, J., & Kouwenhoven, E. A. (2012). The prognostic value of tumour-stroma ratio in triple-negative breast cancer. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 38(4), 307\u2013313.","journal-title":"European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"issue":"12","key":"9764_CR24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI0215234","volume":"109","author":"RS Muraoka","year":"2002","unstructured":"Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S., Gotwals, P. J., Koteliansky, V., & Arteaga, C. L. (2002). Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. The Journal of Clinical Investigation, 109(12), 1551\u20131559.","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"9764_CR25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","volume":"133","author":"D Padua","year":"2008","unstructured":"Padua, D., Zhang, X. H., Wang, Q., Nadal, C., Gerald, W. L., Gomis, R. R., & Massague, J. (2008). TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell, 133(1), 66\u201377.","journal-title":"Cell"},{"issue":"5","key":"9764_CR26","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/bcr2633","volume":"12","author":"F Parisi","year":"2010","unstructured":"Parisi, F., Gonzalez, A. M., Nadler, Y., Camp, R. L., Rimm, D. L., Kluger, H. M., & Kluger, Y. (2010). Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models. Breast Cancer Research, 12(5), R66.","journal-title":"Breast Cancer Research"},{"key":"9764_CR27","volume-title":"C4.5 : programs for machine learning","author":"JR Quinlan","year":"1993","unstructured":"Quinlan, J. R. (1993). C4.5 : programs for machine learning. San Mateo: Morgan Kaufmann Publishers."},{"issue":"6","key":"9764_CR28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi, Y., & Massague, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 113(6), 685\u2013700.","journal-title":"Cell"},{"issue":"15","key":"9764_CR29","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1158\/1078-0432.CCR-13-0804","volume":"19","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y., Schnabel, C. A., Schroeder, B. E., Jerevall, P. L., Jankowitz, R. C., Fornander, T., Stal, O., Brufsky, A. M., Sgroi, D., & Erlander, M. G. (2013). Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 19(15), 4196\u20134205.","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"}],"container-title":["Information Systems Frontiers"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10796-017-9764-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10796-017-9764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10796-017-9764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T08:12:12Z","timestamp":1509955932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10796-017-9764-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["9764"],"URL":"https:\/\/doi.org\/10.1007\/s10796-017-9764-0","relation":{},"ISSN":["1387-3326","1572-9419"],"issn-type":[{"value":"1387-3326","type":"print"},{"value":"1572-9419","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,1]]}}}